Cetera Investment Advisers’s Ocugen OCGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$38.9K Buy
25,451
+15,450
+154% +$23.5K ﹤0.01% 4798
2026
Q1
$18.1K Sell
10,001
-17
-0.2% -$29 ﹤0.01% 4665
2025
Q4
$13.5K Buy
+10,018
New +$14.3K ﹤0.01% 4601
2024
Q4
Sell
-414,701
Closed -$411K 3860
2024
Q3
$411K Buy
+414,701
New +$569K ﹤0.01% 2816
2022
Q4
Sell
-13,332
Closed -$24K 2152
2022
Q3
$24K Sell
13,332
-1,900
-12% -$4.73K ﹤0.01% 1635
2022
Q2
$35K Hold
15,232
﹤0.01% 1784
2022
Q1
$50K Buy
+15,232
New +$53.5K ﹤0.01% 1841

Other funds holding OCGN

Cetera Investment Advisers's OCGN Position: Q2 2026 in Review

Cetera Investment Advisers increased its Ocugen (OCGN) stake by 154% in Q2 2026, buying an estimated $23.5K and bringing the position to 25,451 shares worth $38.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4798.

Cetera Investment Advisers first reported a position in OCGN in Q1 2022 and has held it in 7 quarters since. The position peaked at $411K in Q3 2024. 147 funds tracked by Wall St. Rank hold OCGN as of Q2 2026.

  • Cetera Investment Advisers held 25,451 shares of Ocugen worth $38.9K as of Q2 2026.
  • Cetera Investment Advisers bought 15,450 Ocugen shares in Q2 2026, an estimated $23.5K.
  • Ocugen made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4798 holding.
  • Cetera Investment Advisers first reported a position in Ocugen in Q1 2022 and has held it in 7 quarters since.
  • Cetera Investment Advisers's Ocugen position peaked at $411K in Q3 2024.
  • 147 funds tracked by Wall St. Rank held Ocugen as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.